Before the markets closed today, Trump signed steel and aluminum import tariff proclamations. Art Hogan is the Chief Market Strategist for B. Riley FBR and Wunderlich Securities. He joins to give his reaction to the new tariffs.
Hogan said markets have been reacting since President Trump announced the possibility of tariffs. For many investors, Hogan said the tariffs felt rushed to market, and that drew a lot of concern regarding potential trade and tariff wars.
When it comes to the new tariffs, Mexico and Canada are indefinitely exempt. These two countries represent a large portion of American trade. The tariff also includes a window of 15 days before it goes into effect. This gives other countries the opportunity to negotiate and manage the tariffs.
Hogan says the best scenario would be no tariffs, but this is is a better tariff than initially expected.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
